Taysha Gene Therapies(TSHA) - 2021 Q4 - Earnings Call Transcript

Taysha Gene Therapies (NASDAQ:TSHA) Q4 2021 Earnings Conference Call March 31, 2022 8:00 AM ET Company Participants RA Session II – President, Chief Executive Officer & Founder Kimberly Lee – Corporate Affairs Officer Suyash Prasad – Chief Medical Officer & Head, Research & Development Kamran Alam – Chief Financial Officer Conference Call Participants Elizabeth Webster – Goldman Sachs Joon Lee – Truist Securities Mike Ulz – Morgan Stanley Jack Allen – Baird Kevin DeGeeter – Oppenheimer Gil Blum – Needham an ...